Cost-effectiveness of opportunistic QCT-based osteoporosis screening for the prediction of incident vertebral fractures

Sebastian Rühling, Julian Schwarting, Matthias F. Froelich, Maximilian T. Löffler, Jannis Bodden, Moritz Roman Hernández Petzsche, Thomas Baum, Maria Wostrack, Amir Kaywan Aftahy, Vanadin Seifert‐Klauss, Nico Sollmann, Claus Zimmer, Jan S. Kirschke, Fabian TollensFrontiers in Endocrinology 2023 · DOI

Abstract

Opportunistic quantitative computed tomography (oQCT) screening is a cost-effective ancillary approach for osteoporosis screening and has the potential to prevent a substantial number of vertebral fractures (VFs) if integrated into daily clinical practice.

Introduction

Osteoporosis is frequently referred to as a "silent disease" because bone loss typically occurs without symptoms until a fracture occurs. Vertebral fractures (VFs) are particularly concerning, as they are associated with high mortality rates and significant healthcare expenditures.

The current clinical gold standard for screening is Dual-energy X-ray Absorptiometry (DXA). However, DXA has notable limitations: it is a 2D projection that may overlook early bone deterioration and requires a dedicated appointment, which many at-risk patients fail to schedule. Conversely, millions of 3D Computed Tomography (CT) scans are performed annually for various clinical indications (e.g., oncology or abdominal pain). This study investigates whether "recycling" existing CT data to measure bone mineral density (BMD) via oQCT offers a more efficient and cost-effective method for identifying at-risk patients before fractures occur.

Methods

The researchers developed a state-transition (Markov) model to simulate the health trajectories of hypothetical cohorts of 1,000 men and 1,000 women, all aged 65. The model compared three primary strategies:

  1. No screening: No intervention.
  2. DXA screening: The current standard of care.
  3. oQCT screening: Analyzing routine CT scans already performed for other clinical indications.
Overview of the three different scenarios: No screening, DXA screening, and Opportunistic QCT.

The model tracked patients through four distinct health states: "alive without VF," "alive without VF on treatment," "alive with a VF," and "dead." The simulation utilized a 5-year follow-up period, calculating outcomes in Quality-Adjusted Life Years (QALYs) and 2022 U.S. dollars. To ensure robustness, Monte Carlo simulations (30,000 iterations) were performed to account for variations in costs and clinical assumptions.

Depiction of the Markov model transition states used to simulate patient health journeys.

Data Sources

The Markov model was populated using high-quality parameters from established longitudinal studies and clinical databases:

  • The Rotterdam Study: Provided sex- and age-adjusted incidence rates of vertebral fractures.
  • MrOS & JPOS: Used to determine the diagnostic sensitivity and specificity of DXA and QCT.
  • U.S. Life Tables: Provided background mortality risks.
  • Medicare Procedure Codes: Used to estimate real-world costs of screening and treatment in the U.S.

Results

The study demonstrated that oQCT is more cost-effective and prevents more vertebral fractures than DXA.

  • Health Outcomes: Compared to DXA, oQCT increased QALYs for both sexes (an additional 2.40 per 1,000 women and 1.44 per 1,000 men).
  • Fracture Prevention: oQCT prevented 2.6 additional VFs per 1,000 women and 2.0 additional VFs per 1,000 men compared to DXA.
  • Economic Impact:
    • For women, oQCT was cost-saving, resulting in lower total costs ($3,199,016) compared to DXA ($3,262,934) while providing better health outcomes.
  • For men, the Incremental Cost-Effectiveness Ratio (ICER) was **$17,432 per QALY**, well below the standard U.S. willingness-to-pay threshold of ~$70,000.
  • Robustness: Probabilistic sensitivity analyses showed oQCT remained the cost-effective choice in approximately 88-90% of simulated scenarios.

Discussion

The primary advantage of oQCT lies in its utilization of "free" data. Since the CT scans are already performed for other reasons, the cost is limited to the software analysis. Furthermore, oQCT provides volumetric BMD, which is more accurate than DXA’s 2D area density for predicting fractures. By integrating screening into existing hospital visits, oQCT bypasses logistical hurdles that often prevent patients from receiving DXA scans, thereby closing the "treatment gap."

Limitations and Future Directions

The study's 5-year time horizon is relatively short for a chronic condition; a lifetime horizon might reveal even greater benefits. Additionally, the model focused exclusively on vertebral fractures, excluding hip fractures, which are more costly and lethal. Future work should explore integrating fully automated AI pipelines into clinical workflows to further reduce the costs of oQCT analysis and facilitate widespread adoption.

Conclusion

Opportunistic QCT is a highly cost-effective, and in some cases cost-saving, alternative to DXA for osteoporosis screening. By leveraging existing clinical data, healthcare systems can significantly improve fracture prevention and patient outcomes without the need for additional radiation or patient appointments.

Summary updated

Abstract

oQCT screening is a cost-effective ancillary approach for osteoporosis screening and has the potential to prevent a substantial number of VFs if considered in daily clinical practice.
BibTeX
@inproceedings{ruhling2023cost,
  author = {Sebastian Rühling and Julian Schwarting and Matthias F. Froelich and Maximilian T. Löffler and Jannis Bodden and Moritz Roman Hernández Petzsche and Thomas Baum and Maria Wostrack and Amir Kaywan Aftahy and Vanadin Seifert‐Klauss and Nico Sollmann and Claus Zimmer and Jan S. Kirschke and Fabian Tollens},
  title = {{Cost-effectiveness of opportunistic QCT-based osteoporosis screening for the prediction of incident vertebral fractures}},
  booktitle = {Frontiers in Endocrinology},
  year = {2023},
  doi = {10.3389/fendo.2023.1222041},
}
Figure